Literature DB >> 2438394

Tumours acquire their vasculature by vessel incorporation, not vessel ingrowth.

W D Thompson, K J Shiach, R A Fraser, L C McIntosh, J G Simpson.   

Abstract

This study was designed to investigate the early development of tumour circulation using a transplantable mouse mammary adenocarcinoma. Tumour cells (10(6] were injected subcutaneously into the flank and groups of treated mice were killed at 24 h intervals up to 12 days; the tumours and surrounding tissues being processed by standard histological methods. Sections of tumour were sub-divided into neoplastic tissue, vessels and connective tissue using computer-assisted morphometric techniques: the host tissue around the tumour was similarly quantified for vessels and connective tissue. With increasing tumour size, the proportion of vessels within tumours rapidly increased to reach a plateau of approximately 1.5 per cent of tumour volume, a 400 per cent increase on the vascular density of normal subcutaneous tissue. Within tumours, vascular density was always higher at the periphery than the centre. The most pronounced increase in vascular density affected the host tissue around the tumour. It is not clear why vascular development is most prominent outwith the tumour when postulated angiogenic factors, such as tumour angiogenesis factor, are presumably released within. Our results imply, however, that tumours acquire their vasculature by infiltration into, and expansion between, a network of newly formed vessels in the surrounding connective tissue.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2438394     DOI: 10.1002/path.1711510413

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  28 in total

Review 1.  Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications.

Authors:  Balázs Döme; Mary J C Hendrix; Sándor Paku; József Tóvári; József Tímár
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

2.  The microvasculature of the 7,12-dimethylbenz(a)anthracene (DMBA)-induced rat mammary tumour. I. Vascular patterns as visualized by scanning electron microscopy of corrosion casts.

Authors:  T Kaidoh; T Yasugi; Y Uehara
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

Review 3.  Angiogenesis in brain tumors; pathobiological and clinical aspects.

Authors:  P Wesseling; D J Ruiter; P C Burger
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

Review 4.  Intratumor microvessel density as a prognostic factor in cancer.

Authors:  N Weidner
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

Review 5.  Current concepts of tumor-induced angiogenesis.

Authors:  S Paku
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

6.  Angiomorphology of the human renal clear cell carcinoma. A light and scanning electron microscopic study.

Authors:  A Bugajski; M Nowogrodzka-Zagórska; J Leńko; A J Miodoński
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

Review 7.  Interactions between cancer cells and the microvasculature: a rate-regulator for metastasis.

Authors:  L Weiss; F W Orr; K V Honn
Journal:  Clin Exp Metastasis       Date:  1989 Mar-Apr       Impact factor: 5.150

8.  Morphological aspects of angiogenesis in experimental liver metastases.

Authors:  S Paku; K Lapis
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

9.  Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis.

Authors:  C Li; R Gardy; B K Seon; S E Duff; S Abdalla; A Renehan; S T O'Dwyer; N Haboubi; S Kumar
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

10.  Pimonidazole binding in C6 rat brain glioma: relation with lipid droplet detection.

Authors:  S Zoula; P F J W Rijken; J P W Peters; R Farion; B P J Van der Sanden; A J Van der Kogel; M Décorps; C Rémy
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.